Implication of Transforming Growth Factor–β1 in Chagas Disease Myocardiopathy

Cardiac dysfunction with progressive fibrosis is a hallmark of Chagas disease. To evaluate the involvement of transforming growth factor (TGF)–β1 in this disease, TGF-β1 levels in patients were measured at 3 stages: asymptomatic indeterminate (IND), cardiac with no or slight heart dysfunction (Card...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2002-12, Vol.186 (12), p.1823-1828
Main Authors: Araújo-Jorge, Tania C., Waghabi, Mariana C., Hasslocher-Moreno, Alejandro M., Xavier, Sérgio S., Higuchi, Maria de Lourdes, Keramidas, Michelle, Bailly, Sabine, Feige, Jean-Jacques
Format: Article
Language:English
Subjects:
Antigens
Biological and medical sciences
Biopsies
Cardiomyopathies
Chagas disease
Electrocardiography
Fibrosis
Heart
Heart diseases
Human protozoal diseases
Infectious diseases
Major Article
Medical sciences
Parasites
Parasitic diseases
Protozoal diseases
T lymphocytes
Trypanosomiasis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiac dysfunction with progressive fibrosis is a hallmark of Chagas disease. To evaluate the involvement of transforming growth factor (TGF)–β1 in this disease, TGF-β1 levels in patients were measured at 3 stages: asymptomatic indeterminate (IND), cardiac with no or slight heart dysfunction (Card 1), and cardiac with moderate or severe heart dysfunction (Card 2). All patients had significantly higher circulating levels of TGF-β1 than did healthy persons, and 27% of patients in the Card 1 group had higher TGF-β1 levels than did patients in the IND group. Immunohistochemical analysis of cardiac biopsy specimens showed strong fibronectin staining in the extracellular matrix and staining for phosphorylated Smad 2 (activation of the TGF-β1 signaling pathway) in cell nuclei. The higher levels of latent TGF-β1 observed in patients with myocardiopathy, together with intracellular activation of the TGF-β1 pathway and tissue fibrosis, suggest that TGF-β1 plays an important role in Chagas disease. TGF-β1 may represent a new target for preventive and curative treatments of Chagas disease
ISSN:0022-1899
1537-6613
DOI:10.1086/345882